MedTrace Logo

Eumycetoma Long-term Post-Treatment Follow-Up Study

NCT06514183 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 51

Last updated 2024-07-23

No results posted yet for this study

Summary

To assess the long-term recurrence rate of eumycetoma in clinical trial participants treated in the phase II DNDi-FOSR-04-MYC clinical trial.

Conditions

  • Eumycetoma

Interventions

OTHER

Clinical diagnosis of recurrence

Clinical diagnosis of recurrence

Sponsors & Collaborators

  • Soba University Hospital

    collaborator OTHER

  • Drugs for Neglected Diseases

    lead OTHER

Principal Investigators

  • Borna A Nyaoke, M.D · Drugs for Neglected Diseases initiative

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-26
Primary Completion
2023-06-26
Completion
2023-06-26

Countries

  • Sudan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06514183 on ClinicalTrials.gov